In continuation of our earlier letter dated December 22, 2025 on the captioned subject, we wish to inform you that pursuant to the approval accorded by the board of directors of the Company (the 'Board'), at its meeting held on July 25, 2025 and the shareholders of the Company, pursuant to the special resolution passed in the Annual General Meeting held on September 15, 2025, the Fund Raising Committee of Directors (the 'Committee') has, at its meeting held today i.e. December 22, 2025,